Many doctors and patients came to believe the rise in obesity may be all but biologically inescapable, despite the grave health risks that accompany it
You can discuss with your healthcare provider switching to other FDA-approved affordable alternatives to semaglutide for weight reduction, such as phentermine/topiramate (Qsymia), orlistat (Xenical), and naltrexone/bupropion (Contrave)
In major clinical trials, tirzepatide demonstrated a higher efficacy, with patients achieving up to a 22.5% average reduction in body weight
Endogenous GIP signaling is indispensable for DPP-4 inhibitor-mediated metabolic control in mice
External resources New England Journal of Medicine: Retatrutide Phase 2 Trial for Obesity PMC: Comparative Efficacy of Tirzepatide vs Retatrutide Network Meta-Analysis Nature Medicine: Retatrutide for Metabolic Dysfunction-Associated Steatotic Liver Disease U.S
Example plan pricing screen reviewed on February 19, 2026